precision medicine

Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.

The 2026 Nobel Prize in Medicine has been awarded for optogenetics, a tool used in brain research that allows scientists to control neurons with light. The technique has become a cornerstone of modern neuroscience, enabling precise study of brain circuits. Reports confirming the announcement are circulating widely as the annual Nobel season draws global attention.

Digbi Health says a study of nearly 16,000 of its members found its precision biology-based gastrointestinal care program delivered meaningful relief from irritable bowel syndrome symptoms at scale. The company announced the findings via GlobeNewswire, positioning its DNA- and gut-microbiome-informed approach as an effective alternative to one-size-fits-all treatment for a condition affecting millions worldwide.

The 2026 Nobel Prize in Physiology or Medicine has been awarded to the pioneers of optogenetics, a technique that uses light to control neurons with precision. The method, combining genetics and optics, has transformed neuroscience by allowing researchers to manipulate brain circuits and study behavior. The recognition highlights decades of work that reshaped how science understands the brain.

Shikha Prakash is drawing attention to precision medicine, arguing that the central aim of modern healthcare should be delivering the right treatment to the right patient at the right time. Her remarks, reported by oncology-focused news outlet Oncodaily, underline how genetic profiling and targeted therapies are reshaping cancer care and moving treatment away from one-size-fits-all approaches toward personalised care for every patient.

Vanderbilt University Health has led a new scientific statement outlining opportunities to advance precision kidney medicine for women. The statement highlights how kidney disease presents and progresses differently in women and argues that sex-specific research and tailored treatment approaches could improve diagnosis and care. Experts hope it will spur more research funding and clinical attention to sex differences in nephrology.

The 2021 Nobel Prize in Physiology or Medicine has been awarded to three scientists who developed optogenetics, a technique that uses light to control neurons. The method, combining genetics and optics, has transformed neuroscience by allowing researchers to switch specific brain cells on and off with remarkable precision. Coverage highlights its importance in understanding brain function and potential in treating neurological disorders.

The 2026 Nobel Prize in Physiology or Medicine has been awarded to the scientists behind optogenetics, a technique that uses light to control genetically modified neurons. Optogenetics revolutionized neuroscience by allowing researchers to precisely manipulate brain circuits in living animals, reshaping studies of behavior, Parkinson's disease, vision disorders and other conditions. The award recognizes one of the most influential breakthroughs in modern brain science.

Pediatric oncologist Giselle Sholler is taking part in the WIN Consortium 2026 symposium, where she is discussing precision medicine with international cancer research leaders. The event brings together clinicians and scientists working to tailor cancer treatment to individual patients, and Sholler's participation highlights the growing role of personalized approaches in oncology, including for childhood cancers.

Three scientists have been awarded the Nobel Prize in Physiology or Medicine for work involving shining light on brain activity. The announcement honors research that uses light to study how nerve cells function, a technique that has transformed neuroscience by allowing researchers to observe and control brain cells with precision. The laureates were recognized for discoveries seen as opening new ways to understand the brain.

The 2026 Nobel Prize in Physiology or Medicine has been awarded for discoveries in neuroscience, according to the New York Times. The announcement, made in Stockholm on October 5, recognizes work advancing understanding of the nervous system. Specific laureates and the precise nature of the breakthrough have not been detailed in available coverage.

The Nobel Prize in Physiology or Medicine has been awarded to three scientists for their pioneering work on optogenetics, a technique that uses light to control neurons. The method has transformed neuroscience research, allowing precise manipulation of brain cells and advancing the study of neurological conditions. The announcement is drawing broad attention across international media.

Scientists from Germany and the United States have been awarded the Nobel Prize in Physiology or Medicine for their work on optogenetics, a technique that uses light to control cells, particularly neurons. The method has transformed neuroscience by allowing researchers to manipulate brain activity with unprecedented precision. The award was announced by the Nobel Assembly in Stockholm.

Researchers are reporting advances that combine X-ray technology with quantum sensing, opening new possibilities for imaging and measurement. The development suggests quantum techniques could make X-ray detection more precise, with potential uses in science, medicine and materials research. Details of the teams and institutions involved, and the specific applications being targeted, remain limited in early coverage.

Whole genome sequencing provided a diagnosis in 47% of pediatric cases with suspected neurological conditions, according to reporting by Inside Precision Medicine. The finding highlights the growing role of comprehensive genomic testing in identifying rare neurological disorders in children, where standard diagnostic approaches often fail. Clinicians and researchers are pointing to the result as evidence that genome sequencing should be considered earlier in the diagnostic pathway for affected children.

Scientists have been awarded the Nobel Prize in medicine for their work on light-gated ion channels and optogenetics, a technique that uses light to control the activity of specific cells, particularly neurons. The method has become a powerful tool in neuroscience, allowing researchers to study brain circuits with precision.

The 2026 Nobel Prize in Physiology or Medicine has been awarded for optogenetics, a technique that uses light to control brain cells with remarkable precision. The work, which combines genetic engineering with optical methods, has transformed neuroscience by letting researchers switch specific neurons on and off in living animals. Coverage highlights its role in mapping brain circuits and its potential relevance to treating neurological conditions.

The Nobel Prize in Physiology or Medicine has been awarded to three scientists for their research on light-gated ion channels and optogenetics, a technique that uses light to control the activity of cells, particularly neurons. The work has transformed neuroscience, allowing researchers to switch specific brain circuits on and off with precision.

The 2025 Nobel Prize in Physiology or Medicine has been awarded for the discovery of light-activated proteins and their application in neuroscience, a technique known as optogenetics. By making brain cells responsive to light, the method allows researchers to switch specific neurons on and off with precision, transforming the study of brain circuits and disorders such as Parkinson's disease. Scientists worldwide have hailed the award as recognition of a technology that reshaped modern neuroscience.

The 2025 Nobel Prize in Physiology or Medicine has been awarded for research using light-based techniques to map the brain. The award, announced in Stockholm, recognises work that allows scientists to observe and chart brain activity with unprecedented precision. The Financial Times reported the announcement, and the prize is once again drawing global attention to advances in neuroscience and optical imaging methods.

MIT researchers have developed an aquabot — a paper-thin swimming robot powered by living muscle cells rather than motors or batteries. The cell-driven swimmer can navigate its way through a maze, demonstrating precise, untethered movement at tiny scales. The work highlights how biological actuators could enable soft, miniature robots for medicine or environmental sensing, and it is drawing attention across robotics and biotech communities.

The 2025 Nobel Prize in Physiology or Medicine has been awarded to three scientists for their development of optogenetics, a technique that uses light to control neurons. The method has transformed neuroscience, allowing researchers to precisely manipulate brain circuits and study conditions such as Parkinson's disease, epilepsy and depression. News outlets are highlighting the pioneering work and its impact on medical research.

CellsBin has raised a Series A round led by 108 BioCapital to advance its rare-cell intelligence platform. The company develops technology for detecting and analyzing rare cells, an area of growing interest in diagnostics and life sciences research. The funding is expected to support further development of its platform as investor attention on biology and precision-medicine tools continues to build.

Two German researchers and a US-based scientist have been awarded the Nobel Prize in Physiology or Medicine for their work on optogenetics, a technique that uses light to control nerve cells. The method has transformed neuroscience by letting scientists switch specific neurons on and off with precision, opening new paths for studying brain disorders.

Three scientists have been awarded the Nobel Prize in Physiology or Medicine for their discoveries concerning optogenetics, a technique that uses light to control the activity of neurons. The work has transformed neuroscience research, allowing precise manipulation of brain cells in living tissue and opening new paths for studying and potentially treating neurological conditions.

UChicago Medicine has appointed Josh Denny, a national leader in precision medicine, to a new senior leadership position. Denny is known for his work in genomics and large-scale biomedical research, and his arrival signals the academic health system's intent to expand precision medicine efforts. Details about his exact title and start date were not included in the announcement.

New findings reported by Inside Precision Medicine indicate that regular exercise improves cognitive function and may slow biological aging in breast cancer survivors. The research adds to growing evidence that physical activity can counter some of the mental and cellular effects of cancer treatment, offering patients a practical way to support recovery and long-term health after diagnosis.